Preliminary studies reveal conolidine might inhibit precise ion channels, lowering neuronal excitability and restricting agony indicators. This system is especially applicable in neuropathic soreness, wherever irregular signaling brings about persistent pain. In addition, conolidine appears to influence G protein-coupled receptor (GPCR) pathways in